Novan’s Phase 2 Molluscum Contagiosum Trial Fully Enrolled: Top Line Results Targeted in November Biotech Investing
Dermira’s QBREXZA (glycopyrronium) Cloth Is Now Available in Pharmacies Nationwide Pharmaceutical Investing
AVROBIO Receives No Objection to Clinical Trial Application from Health Canada for AVR-RD-02 Gene Therapy for Gaucher Disease Biotech Investing
AVROBIO Announces Updated Clinical Data for AVR-RD-01 Gene Therapy in Fabry Disease Biotech Investing
Therma Bright Provides Corporate Update on Pain Relief Device Incorporating Medicinal Cannabis, Further Testing of TherOZap(TM) Technology Biotech Investing
Canntab Enters LOI for Bi-Lateral Sales & Distribution and Cannabis Oil Supply Cannabis Investing News
Big News Roundup: Relay Medical To Commence Trading in United States as RYMDF; BriaCell Announces Positive Phase IIa Proof of Concept Data in Advanced Breast Cancer; Initiates Combination Study; Kalytera Announces Progress with Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain Biotech Investing
Oncolytics Biotech Enters into Common Stock Purchase Agreement for up to US$26 Million with Lincoln Park Capital Biotech Investing
Intra-Cellular Therapies Completes Submission of New Drug Application for Lumateperone for Treatment of Schizophrenia Pharmaceutical Investing
Kalytera Announces Next Share Issuance under Payments Agreements with Salzman Group Cannabis Investing News
